Cargando…
Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma
N6-methyladenosine (m6A) RNA methylation has been implicated in various malignancies. This study aimed to identify prognostic signature based on m6A methylation regulators for hepatocellular carcinoma (HCC) and provide candidate targets for HCC treatment. In this study, the expression levels, progno...
Autores principales: | Wu, Shuang, He, Guifang, Liu, Shihai, Cao, Yongxian, Geng, Chao, Pan, Huazheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108408/ https://www.ncbi.nlm.nih.gov/pubmed/35582419 http://dx.doi.org/10.7150/ijms.69645 |
Ejemplares similares
-
Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma
por: Wu, Shuang, et al.
Publicado: (2022) -
N6-methyladenosine methylation-related genes YTHDF2, METTL3, and ZC3H13 predict the prognosis of hepatocellular carcinoma patients
por: Wang, Yun, et al.
Publicado: (2022) -
Dermatopontin inhibits WNT signaling pathway via CXXC finger protein 4 in hepatocellular carcinoma
por: Liu, Shihai, et al.
Publicado: (2020) -
N(6)-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
por: Lin, Xian, et al.
Publicado: (2022) -
Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2020)